New enzymes and protein engineering have advanced biocatalysis processing toward commercial acceptance. Technology and economic roadblocks must be overcome for the process to be widely embraced by pharma.
Greg Holgate
Advertisement
Greg Holgate is biocatalysis chemist with Sterling Pharma Solutions.
Articles by Greg Holgate
Advertisement
Latest Updated Articles
Seeking Economies of Scale for BiocatalysisPublished: October 15th 2021 | Updated:
Advertisement
Advertisement
